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Summary.-Experiments conducted in vitro are described which indicate that a
family of specifically substituted phosphoramides may share the carcinogenic pro-
perties displayed by the structurally novel carcinogen, hexamethylphosphoramide
(HMPA). Most of the analogues tested only gave a positive response in vitro when
using a substantially modified liver homogenate activation system (S-9 mix). The
analogy drawn in our earlier paper between this new class of potential carcinogens
and the nitrosamine carcinogens, has been strengthened. The following compounds
gave a positive response in the cell transformation assay of Styles: hexamethyl-
phosphoramide (HMPA), hexamethylphosphorous triamide, hexamethylphosphoro-
thioic triamide, tripiperidinophosphine oxide, phosphorothioic trimorpholide and
diethoxymorpholinophosphine oxide (DEMPA).
A RECENT inhalation study has demon-
strated that hexamethylphosphoramide
(HMPA) (I in Fig. 1) is a powerful rodent
carcinogen (Zapp, 1975; Lee et al., 1978).
Since this property had not previously
been associated with phosphoric amides, it
became of interest to investigate how
general this effect was among compounds
structurally related to HMPA. In order to
study chemical structure/biological acti-
vity relationships without initially under-
taking further long-term animal tests, use
must be made ofan in vitro carcinogenicity
assay. In an earlier paper (Ashby et al.,
1977) we described an evaluation ofHMPA
and several of its structural analogues in
2 such in vitro assays. The conclusions
reached at that time were as follows:
(1) Of the in vitro tests available to us,
the cell transformation assay of
Styles (1977) was best suited to
studying this class of potential
carcinogen.
(2) That any further invitrostudieswith
analogues of HMPA should be con-
ducted in the presence of the appro-
priate positive and negative chemi-
cal class controls, HMPA (I) and
phosphoric trianilide (II) respect-
ively.
(3) That the broad structural require-
ments for carcinogenicity observed
for the nitrosamine carcinogens (an
example of which is dimethylnitro-
samine, DMN (III); Druckrey 1975)
miight also apply to this new class of
phosphoramide carcinogens.
The present paper describes experiments
designed to evaluate a prediction we made
in our previous paper (Ashby et al., 1977)
based upon point (3) above, namely, that
compounds such as trimorpholinophos-
phine oxide (IV) would possess carcino-
genic potential due to their structural re-
lationship to the putatively analogous
carcinogen nitrosomorpholine (V). The
additional compounds synthesized and
tested for this purpose were hexamethyl-
phosphorous triamide (VI), hexamethyl-
phosphorothioic triamide (VII), tripiperi-
dinophosphine oxide (VIII), phosphoro-
thioic trimorpholide (IX) and diethoxy-
morpholinophosphine oxide (DEMPA, X).
Each has been evaluated in the cell trans-N P=O
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FIG. 1. Structural formulae of compounds mentioned in text.
formation assay of Styles, under 2 differ-
ent conditions of metabolic activation.
MATERIALS AND METHODS
Chemicals8.-N.M.R. spectra were recorded
at 60 MHz on a Perkin-Elmer R-12 and at
100 MHz on a Varian HA lOOA or HA lOOD
instrument, and were consistent with the
required structures. Micro-analytical data for
C, H and N were within 0400 ofthe theoreti-
cal values.
Hexamethylphosphoric triamide (I) and
phosphoric trianilide (II) have been described
by us previously (Ashby et al., 1977), and the
same batches of material were used in the
present study.
Hexamethylphosphorous triamide (VI) was
purchased from Aldrich Chemical Company
Ltd, Gillingham, Dorset and was redistilled
to give a clear colourless liquid b.p. 52-53°/16
mm (Burgada, 1963, records b.p. 51°/15 mm).
Hexamethylphosphorothioic triamide (VII)
was prepared by reaction of hexamethyl-
phosphoric triamide (I) with sulphur and
purified according to the method described
by Vetter & Noth (1963). The appropriate
distillation fraction was redistilled to give the
product, b.p. 65-65-5°/1 mm (Vetter & Noth,
1963, report b.p. 630/1.2 mm); N.M.R. (100
MHz) showed hexamethylphosphoric tria-
mide (I) present at a just detectable level,
estimated to be 0 85% (82-65 d, [(CH3)2N-13-
PS), 82 60 (d, [(CH3)2N-]3-PO) measured in
deuterochloroform. Keat & Shaw (1968)
report 7-38
- ([(CH3)2N]3-PS) and 7 40
-
([(CH3)2N]3-PO) measured in carbon tetra-
chloride.
Tripiperidinophosphine oxide (VIII) Phos-
phoryl chloride (34-25 g 0-25 mol) was added
dropwise over 15 min to a stirred solution of
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freshly distilled piperidine (128 g 1-5 mol) in
petroleum ether b.p. 60-800 (250 ml) keeping
the temperature below 25°C by cooling in an
ice bath. After stirring overnight at labora-
tory temperature, the reaction mixture was
filtered to remove piperidine hydrochloride
which was washed with petroleum ether. The
combined filtrate was evaporated and the
residual yellow oil distilled collectingthewhite
oily semi-solid b.p. 185-190°/1 mm. This ma-
terial contained some piperidine hydro-
chloride which had sublimed simultaneously,
therefore, the semi-solid mass was extracted
with petroleum ether (150 ml) and filtered.
Evaporation of the filtrate gave 39-3 g
(58-70%) of a clear, pale, yellow oil which
slowly crystallized to give the product as
colourless needles (after being scratched with
a glass rod). The pure product was extremely
hydroscopic and analysed as a hemihydrate.
Phosphorothioic trimorpholide (IX) was pro-
vided by ICI Organics Division and purified
by recrystallisation from isopropanol as large
colourless needles m.p. 145-5-1460 (Audrieth
& Toy, 1942 report m.p. 145-5-1460C).
Diethoxymorpholinophosphine oxide (X)
(DEMPA) was prepared by the method of
Saunders et al. (1948) and had b.p. (64-68°
(0-015 mm) (Saunders et al., 1948) report b.p.
137° at 11 mm).
A solution of each chemical in dimethyl-
sulphoxide (DMSO, BDH Chemicals Ltd.,
Poole, Dorset) was prepared just prior to
testing.
Cell Transformation Assay.-The methods
employed when testing a compound for po-
tential carcinogenicity using growth of mam-
malian cells in semi-solid have been described
in detail (Styles, 1977). The cells used in this
study were two distinct sub-clones of BHK
21/C13, the first of which had a spontaneous
transformation frequency of 50/106 survivors
whilst the later clone, which is now being used
routinely, had a spontaneous transformation
frequency of 10/106 survivors. In all experi-
ments with both sub-clones, a positive result
was recorded when the transformation fre-
quency/106 survivors at the LD50 dose-level
exceeded 5x the control frequency/106 sur-
vivors. Thus, with the earlier clone, the
threshold frequency for a positive response
was 250 transformations/106 survivors, and
with the later clone 50 transformations/106
survivors. This difference is seen as a change
in the position ofthe horizontal dotted line in
Figure 2. All experiments were conducted in
the presence ofthe appropriate chemical class
positive and negative controls (Ashby &
Purchase, 1977), namely, HMPA (I) and the
trianilide (II) respectively.
Rat liver homogenate (S-9 mix).-The S-9
fraction was prepared from Aroclor 1254
induced rats, as previously described (Styles,
1977). The S-9 fraction was then combined
with co-factors to give the S-9 mix. In the
present experiments two separate protocols
for preparing and using the S-9 mix were
used. The first was the same as we have pre-
viously employed with this assay (Styles,
1977; Ashby et al., 1977), i.e. 10 p1 per incu-
bation tube ofa mix consisting ofS-9 fraction
and co-factors in the ratio 1:9. The second
involved adding 50 yd per incubation tube of
a mix consisting ofS-9 fraction and co-factors
in the ratio 1: 1.
RESULTS
Four separate experiments were con-
ducted on the complete set of test com-
pounds (see below). Duplicate plates were
used at each dose level with each com-
pound, DMSO acting as the test negative
control. A tabulation ofthe 4 experiments
conducted is shown in the Table. Experi-
ment 2 is a repeat of Experiment 1 and
both were conducted using the standard
S-9 mix (1:9, 10 l l). Experiment 4 is a
repeat of Experiment 3 and both were
conducted using the modified S-9 mix (1:1,
50 rl). The responses given by each chemi-
cal have been averaged for Experiments 1
& 2 and for Experiments 3 & 4 and each
shown as a complementary pair in Figure
2. Those figures representing data gener-
ated using the modified S-9 mix (50 1A 1: 1)
are indicated by an asterisk close to the
chemical structure. Figure 2 shows the
response given by HMPA (I) [as an aver-
age of 6 separate experiments (spaced over
2 years) using the earlier clone and stan-
dard S-9 mix (Fig. 2a), as tested using
standard S-9 mix but using the new clone
(Fig. 2b), and asin thepresentexperiments
(Fig. 2c & d)], hexamethylphosphorous
triamide (VI) (Fig. 2e & f), hexamethyl-
phosphorothioic triamide (VII) (Fig. 2g &
h), the morpholine derivative IX (Fig. 2i
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& j), the piperidine derivative VIII (Fig.
2k & 1), DEMPA X (Fig. 2m & n) and
phosphoric trianilide (II) (Fig. 2o & p). On
each occasion of testing hexamethylphos-
phoramide (HMPA, I) and hexamethyl-
phosphorous amide (VTI) gave a positive
response, and the trianilide (II) gave a
negative response. The response given by
the remaining compounds varied with the
S-9 mix used, as summarized in the Table,
and discussed in the text. Comparison of
the responses given by HMPA (I) under
the same conditions of metabolic activa-
tion yet using the 2 different clones
421
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(Fig. 2a & b) establishes that within the necessary fact to establish in order that
limits of these experiments the response experiments using different clones could
given by a chemical is independent of the be compared.
spontaneous transformation frequency of
the clone. The point has been confirmed DISCUSSION
with other carcinogens, such as Butter We have previously suggested that the
Yellow (Ashby et al., 1978a), and was a carcinogenicity of HMPA (I) may not be
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FiG. 2. Survival andl transformation of BHK cells (BHK 21 C1/13) treated with compounds (I)
(a-d), (VI) (e, f), (VII) (g, h), (IX) (i, j), (VIII) (k, 1), (X) (m, n) and (II) (o, p). Data marked with
an asterisk were generated using the modified S-9 mix (see Materials and Methods). Dashed lines
represent 50%0 survival (LD50) and 5 x control frequency of transformants per 106 survivors.
uniquely associated with this particular
phosphoramide but may be shared by
other appropriately substituted phos-
phoramides. Inaddition, wehavesuggested
that the metabolic activation of HMPA,
both as a mutagen and as a carcinogen,
may proceed in a manner superficially
similar to that undergone by the nitrosa-
mine carcinogens. In particular, this would
involve initial alpha-hydroxylation of one
of the alkyl (methyl) groups followed by
the release of an aldehyde (formaldehyde)
and/or an active alkylating species. Cer-
tainly, both dimethylnitrosamine (III) and
HMPA (I) generate formaldehyde in vitro
upon incubation with rat liver derived S-9
mix (Ashby et al., 1977) and in both series,
derivatives which lack a free alpha-posi-
tion, such as diphenylnitrosamine (XI)
and phosphoric trianilide (II), are inactive
in vitro as cell transforming agents and as
bacterial mutagens (Ashby et al., 1977).
The advantage to be gained by establish-
ing some form of analogy between these 2
classes ofcarcinogens is that a lot is known
about the structural pre-requisites for
carcinogenicity within the nitrosamine
class (Druckrey, 1975) but virtually noth-
ing is known concerning this property in
the phosphoramide class. Thus, if a link
between these two classes can be estab-
lished, a rapid and local stance could be
adopted for evaluating the possible car-
cinogenicity of hitherto untested members
ofthis new class ofcarcinogens. Thefollow-
ing observations on the experiments des-
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cribed earlier contribute to a more accur-
ate definition of this putative link.
It would be anticipated that the S-9 mix
would be capable of oxidizing the phos-
phorous atom of hexamethylphosphorous
amide (VI) thereby generating HMPA (I)
in vitro. Assuming that the oxidative capa-
city of the S-9 mix approximates to that
in vivo, the positive assay response pro-
duced by VI probably indicates that the
presence or absence of the P-=O oxygen
group in a derivative of HMPA is not of
major importance when assessing that
compound's potential for causing cancer.
Likewise, we anticipated that the S-9
mix would convert the thio (=S) group of
hexamethylphorothioic triamide (VII)into
an oxo (z O) group, therebv yielding
IIMPA in vitro, and that this compound
would thereby give a positive assay re-
sponse. The fact that this was realized only
when using the modified S-9 mix may be
due to inactivation of the standard S-9
mix by sulphur radicals generated during
the thione hydrolysis process (De Matteis,
1977). The modified activation system had
a greater quantity of S-9 fraction per in-
cubation tube (5.8 mg/ml as opposed to
0245 mg/ml of total test medium) which
may have allowed any destructive effects
produced on the standard activation sys-
tem to be absorbed, leaving a competent
metabolic system capable of activating
the derived HMPA. Therefore, the positive
effects observed for HMPA (I), its deoxy-
derivative (VI) and its thio-derivative
(VII) indicate that the groups P_O, P
and P S should beregarded as equivalent
(in particular to P O) when new deriva-
tives of HMPA are to be selected as
candidates for in vitro evaluation.
The three alicyclic ring analogues of
HMPA, compounds IX, VIII and X, were
each negative when tested using the stan-
dard S-9 mix, and each was relatively non-
toxic to the cells. However, whenthemodi-
fied S-9 mix was employed, cell toxicity
increased dramatically and positive trans-
formation effects were observed in each
case. A similar effect was observed follow-
ing modifications made to the chemical
structure of a series of thiophene deriva-
tives (Ashby et al., 1978b). In that case the
overall metabolism of the compounds was
influenced by chemical features, whilst in
the present experiments similar changes
have arisen following changes made to the
S-9 mix. The above 3 phosphoramide deri-
vatives have, therefore, been defined as
both reproducibly positive and reprodu-
cibly negative dependent upon the condi-
tions ofin vitro activation. In both circum-
stances the appropriate chemical class con-
trol substances were correctly identified.
Were either of these controls to have
changed their testresponsewiththechange
in S-9 mix, serious doubts about the likely
in vivo significance of the above three re-
versible positive results could have been
raised. As it has been demonstrated that
the change made to the cell clone (altered
frequency of spontaneous transformation)
could not have produced these changed
responses, the change in S-9 mix musthave
been responsible.
A possible explanation for these effectsis
that one or more ofthe critical steps in the
activation of these 3 compounds is more
sensitive to the constitution of the activa-
tion system, or to the physicochemical
environment of activation, than are the
corresponding steps in the activation of
HMPA, although even in that case the
transformation frequency is marginally
increased when using the modified S-9
mix (Fig. 2d). It could, therefore, be
inferred that whilst these 3 compounds
have been defined as potential carcinogens,
the range ofmetabolic circumstancesunder
which this potential will be expressed may
be more limited than in the case ofHMPA.
If it could be shown that either one of the
activation systems used was more relevant
than the other to the situation in vivo, then
firm predictions of the likely carcinogenic
potential of these compounds could be
made. This is not possible, in fact it is
likelythat both ofthese separate metabolic
conditions, togetherwith many others, will
occur in vivo, if only transiently or locally
in some tissues. The use of appropriate
chemical class controls, therefore, contri-
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buted to an interpretation of the experi-
mental data and may have helped to de-
fine some limiting aspects of the potential
carcinogenicity of compounds IX, VIII
and X.
It has already been demonstrated that
changes made to the quantity of S-9 mix
added to the incubation medium of an in
vitro assay, or changes made to the S-9
fraction:co-factor ratio can modulate the
in vitro response given by achemical (Ames
et al., 1973; 1975). The present example
represents the extreme case of passing
from inactivity to activity in vitro follow-
ing such changes. Whilstit could, therefore,
be argued that all in vitro evaluations of
new chemicals should be carried out using
a wide range of S-9 mixes, this may be un-
necessarily extreme. Rather, it may be
necessary only to evaluate compounds
using a small, but widely separated range
of S-9 mixes in cases where an initially
derived negativeresponseisnotcompatible
with what is already known about, or
expected from, an individual chemical or
class of chemicals. We have discussed else-
where the wider implications raised by
such changes to an observed in vitro re-
sponse induced by changes made to the
S-9 mix (Ashby et at., 1978a; Ashby &
Styles 1978a, b).
It therefore seems likely that a family
ofspecifically substituted phosphoramides,
rather than only HMPA itself, may have
carcinogenic potential. Further, a unifying
thread may connect this new class of
potential carcinogens with the well estab-
lished class of nitrosamine carcinogens.
As a result it is suggested that the struc-
tural criteria established for the latter
class of carcinogens may be of help in
delineating the most likely potential
carcinogens within the phosphoramide
class.
Hexamethylphosphoramide is an ex-
tremely potent carcinogen for rats, ex-
posure to 0-02/106 in air producing
positive effects. It is, therefore, tempting
to assume that any new carcinogens of
this class will also be abnormally potent,
but this idea should be approached with
caution. The tumours produced by
HMPA originated in the nasal region,
during an inhalation study, and this may
represent preferrential access and concen-
tration ofthis unusual solvent in the mem-
branes surrounding the convoluted tur-
binate bones of rats. Not only is this bone
structure unrepresentative ofman, butany
solid derivatives of HMPA (such as VIII
and IX) would be evaluated for carcino-
genicity via the oral route, and would,
therefore, be unlikely to present this prob-
lem. These compounds might well be car-
cinogenic, but they may possess a much
lower potency than HMPA and a different
target organ specificity.
There remains one apparent inconsis-
tency with this chemical class analogy;
that is, that after alpha-hydroxylation and
formaldehyde release, dimethylnitrosa-
mine (III) generates methyldiazonium
hydroxide (XII), an active alkylating
species (and one which is the assumed
effective mutagen and carcinogenic ini-
tiator). After a similar sequence of bio-
chemical changes had taken place
with HMPA, pentamethylphosphoramide
(XIII) would be formed, a compound not
expected to possess alkylating properties.
This could indicate that the reaction
mechanism proposed for the activation of
nitrosamine carcinogens (Druckrey, 1975)
is only one ofseveral possible mechanisms,
another of which might also be consistent
with the activation ofHMPA as a mutagen
and carcinogen. Consideration of these
possible mechanisms will be discussed
elsewhere.
IThe atuthors wish to thank MI N. Pritchard, MIrs
S. Rae an(i NMrs. B. Pell for technical assistance.
REFERENCES
AMlES, B. N., DURSTON, W. E., YAATASAKI, E. &
LEE, F. D. (197:3) Carcinogens are mutagens: A
simple test system combining liver homogenates
for activation ancd bacteria for detection. Proc.
Natl. Acad. Sci. U.S.A., 70, 2281.
AMES, B. N., MCCANN, J. & YAMIASAKI, E. (1975)
Methods for (letecting carcinogens an(1 mutagens
with the salmonella/mammalian-microsome muta-
genicity test. Mutat. Res., 31, 347.
ASHBY, J. & PURCHASE, I. F. H. (1977) The selection
ofappropriate chemical class controls for use withCARCINOGENIC EVALUATION OF HMPA ANALOGUES 427
short-term tests for potential carcinogenicity.
Ann. Occup. Hyg., 20, 297.
ASHBY, J. &.STYLES, J. A. (1978a) Does carcinogenic
potency correlate with mutagenic potency in the
Ames assay. Nature, 271, 452; 274, 19 (subsequent
replies).
ASHBY, J. & STYLES, J. A. (1978b) Comutagenicity,
competitive enzyme substrates and in vitro car-
cinogenicity assays. Mutat. Re8., 54, 105.
ASHBY, J., STYLES, J. A. & ANDERSON, D. (1977)
Selection of an in vitro carcinogenicity test for
derivatives of the carcinogen hexamethylphos-
phoramide. Br. J. Cancer, 36, 564.
ASHBY, J., STYLES, J. A., ANDERSON, D. & PATON,
D. (1978b) Thiophene analogues ofthe carcinogens
benzidine and 4-aminobiphenyl; evaluation in
vitro. Br. J. Cancer, 38, 521
ASHBY, J., STYLES, J. A. & PATON, D. (1978a) In
vitro evaluation of some derivatives of the car-
cinogen butter yellow: implications for environ-
mental screening, Br. J. Cancer, 38, 51.
AUDRIETH, L. F. & ToY, A. D. F. (1942) The aquo
ammono phosphoric acids III. The N-substituted
derivatives of phosphoryl and thiophosphoryl
triamides as hydrogen binding agents, J. Am.
Chem. Soc., 64, 1553.
BURGADA, R. (1963) Contribution a l'etude des
amides organiques de l'acide phosphoreux, Ann.
Chimie, 8, 347.
DE MATTEIS, F. (1977) Hepatotoxicity of carbon
disulphide and of other sulphur containing
chemicals: possible significance oftheirmetabolism
by oxidative desulphuration. In Biological Reac-
tive Intermediate8, Formation, Toxicity and In-
activation. Eds Jollow, D. J., Kocsis, J. J., Snyder,
R. & Vaimo, H. New York and London: Plenum
Press.
DRUCKREY, H. (1975) Chemical carcinogenesis of
N-nitroso compounds. Gann Monog. Cancer Re8.,
17, 107.
KEAT, R. & SHAw, R. A. (1968) Phosphorus-nitro-
gen compounds part XXVI. The influence of
benzene on the 1H NMR Spectra of some mono-
nuclear phosphorus (V) amides and dimethyl-
aminocyclotriphosphazatrienes. J. Chem. Soc.,
703.
LEE, K. P., TROCHIMOWICZ, H. J. & SARVER, J. W.
(1978) Induction ofnasal tumours in rats exposed
to hexamethylphosphoramide (HMPA). Lab.
Inve8t., 36, 344.
SAUNDERS, B. C., STACEY, G. J., WILD, F. &
WILDING, I. G. E. (1948) Esters containing
phosphorus Part V. Esters of substituted phos-
phoric and phosphorous acids. J. Chem. Soc., 699.
STYLES, J. A. (1977) A method of detecting carcino-
genic organic chemicals using mammalian cells in
culture. Br. J. Cancer, 36, 558.
VETTER, H. J. & N6TH, H. (1963) Dialkylamino-
phosphane IV, Additionen und Substitutionen am
tris(dimethylamino)phosphan, P(NMe2)3. Ber, 96,
1308.
ZAPP, J. A. (1975) Inhalation toxicity of hexa-
methylphosphoramide. Am. Ind. Hyg. A8s. J., 36,
916.
29